Liver metastases from colorectal cancer: The turning point

Journal of Clinical Oncology

Volumn 20, Issue 6, 2002, Pages 1442-1445

  Nordlinger, Bernard ^a   Rougier, Philippe ^a  

^a HÔPITAL AMBROISE PARÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IRINOTECAN; OXALIPLATIN;

CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; COLORECTAL CARCINOMA; CRYOTHERAPY; DISEASE ASSOCIATION; EDITORIAL; HUMAN; HYPERTHERMIC THERAPY; LIVER METASTASIS; MORTALITY; PALLIATIVE THERAPY; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; TREATMENT PLANNING;

EID: 0037087690     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2002.20.6.1442     Document Type: Editorial

References (20)

1. Expectancy of primary chemotherapy in patients with advanced asymptomatlc colorectal cancer: A randomized trial
2. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: A multicentre randomised trial
3. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer
4. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer
5. Surgical resection of colorectal carcinoma metastases to the liver: A prognostic scoring system to improve case selection, based on 1568 patients
6. Resection of the liver for colorectal carcinoma metastases: A multi-institutional study of patterns of recurrence
7. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases
8. Prospective study of prognostic factors in patients with unresected hepatic metastases from colorectal cancer
9. Survival benefit of repeat liver resections for recurrent colorectal metastases: 143 cases
10. Combined modality treatment for resectable metastatic colorectal carcinoma to the liver: Surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy - An intergroup study
11. Locoregional chemotherapy for metastatic colorectal cancer to the liver
12. Reappraisal of hepatic arterial infusion in the treatment of non resectable liver metastases from colorectal cancer
13. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: Long-term results of a prospective randomized trial
14. Randomized, multicenter trial of fluorouracil plus leucovorin administrated either via hepatic artery or intravenous infusion versus fluorodeoxyuridine administrated via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma
15. Regional chemotherapy for hepatic metastases of colorectal carcinoma (continuous intra-arterial versus continuous intra-arterial/intravenous therapy): Result of a controlled clinical trial
16. Sequential intrahepatic fluorodeoxyuridine and systemic fluorouracil plus leucovorin for the treatment of metastatic colorectal cancer confined to the liver
17. A phase I-II study of hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone (DEX) in combination with systemic (SYS) irinotecan (CPT-11) after resection of hepatic metastases (Mets) from colorectal cancer
18. Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer
19. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer
20. Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery